Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Amarillo Biosciences completes enrollment for phase II study on Sjogren's syndrome

Aug. 12, 1997

Cephalon reports cysteine/serine protease inhibitors with broad therapeutic potential

Aug. 11, 1997

Antiarthritic activity of British Biotech MMP/TNF-alpha inhibitors

Aug. 8, 1997

Nabumetone shows superior safety profile in comparative study

Aug. 6, 1997

Neoral as rheumatoid arthritis therapy launched in U.S.

Aug. 1, 1997

Cell adhesion inhibitors disclosed by Hoechst

July 31, 1997

Prosorba column trial for rheumatoid arthritis to continue

July 30, 1997

Tularik identifies protein kinase involved in inflammatory pathways

July 28, 1997

Positive efficacy profile reported for Immunex's TNF receptor

July 28, 1997

Novel antiarthritic drug in development at P&U

July 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...